sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
10-Feb-2016 21:37
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 976-1000 out of 1158.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

Public Release: 16-Jul-2014
Food Control
Preventing foodborne illness, naturally -- with cinnamon
Cinnamomum cassia oil was shown to be effective as a natural antibacterial agent against several strains of Shiga toxin-producing Escherichia coli, known to the US Centers for Disease Control and Prevention as 'non-O157 STEC'. The study results add to a body of knowledge that will help improve food safety and reduce or eliminate cases of food poisoning and related deaths.

Contact: Meijun Zhu
Washington State University

Public Release: 15-Jul-2014
New assay to spot fake malaria drugs could save thousands of lives
Chemists have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine -- an enormous and deadly problem in the developing world. If widely used it could help save hundreds of thousands of lives.

Contact: Vincent Remcho
Oregon State University

Public Release: 15-Jul-2014
Nature Reviews Cardiology
Cardiac patients underserved globally due to lack of rehab programs: York University researcher
The article, Global availability of cardiac rehabilitation, published online at Nature Reviews Cardiology, indicates that while 68 per cent of high-income countries have cardiac rehabilitation, only 23 per cent of low-income and middle-income countries do, despite the fact that 80 per cent of deaths from heart disease occur in these countries.

Contact: Gloria Suhasini
416-736-2100 x22094
York University

Public Release: 15-Jul-2014
PLOS Medicine
Rollout strategy for diagnostic test in India may impact TB
Xpert MTB/RIF, a recently implemented tuberculosis (TB) test, has the potential to control the TB epidemic in India, but only if the current, narrow, implementation strategy is replaced by a more ambitious one that is better funded, also includes the private sector, and better referral networks are developed between public and private sectors, according to new research published in this week's PLOS Medicine.
Bill & Melinda Gates Foundation

Contact: Maya Sandler

Public Release: 14-Jul-2014
Emerging Infectious Diseases
Sierra Leone samples: Ebola evidence in West Africa in 2006
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus. The study, authored by USAMRIID and published in this month's edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006 -- well before the current outbreak.
Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System, US Department of Defense Cooperative Biological Engagement Program

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 10-Jul-2014
The Lancet
Injected vaccine could help eradicate polio
Re-introducing a type of polio vaccine that fell out of favor in the 1960s could hasten eradication of the disease, according to new research.
Bill & Melinda Gates Foundation

Contact: Sam Wong
Imperial College London

Public Release: 9-Jul-2014
Cell Host & Microbe
The 'yin and yang' of malaria parasite development
'Herculean study' into malaria parasite development is completed -- bringing scientists closer to disrupting the life-cycle of this highly efficient parasite.
Medical Research Council

Contact: Lindsay Brooke
University of Nottingham

Public Release: 4-Jul-2014
64th Lindau Nobel Laureate Meeting
Conclusion of the Lindau Nobel Laureate meeting
The 64th Lindau Nobel Laureate Meeting has ended with a panel discussion entitled 'Science for the benefit of mankind' on Mainau Island, Germany, today. In the panel discussion it was repeatedly emphasised that basic research forms the essential basis for applied science and should therefore be supported equally as translational research.

Contact: Christian Schumacher
Lindau Nobel Laureate Meetings

Public Release: 4-Jul-2014
The Obstetrician & Gynaecologist
Effects of conflict on women's reproductive health need to be managed sensitively
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today in The Obstetrician & Gynaecologist.

Contact: Nicole Weingartner

Public Release: 3-Jul-2014
Angewandte Chemie
Low-cost TB test means quicker, more reliable diagnosis for patients
A new test for tuberculosis developed at the Texas A&M Health Science Center could dramatically improve the speed and accuracy of diagnosis for one of the world's deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
Wellcome Trust

Contact: Holly Lambert Shive
Texas A&M University Health Science Center

Public Release: 1-Jul-2014
PLOS Biology
New compound blocks 'gatekeeper' enzyme to kill malaria
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs.

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Malaria parasite manipulates host's scent
Malaria parasites alter the chemical odor signal of their hosts to attract mosquitoes and better spread their offspring, according to researchers, who believe this scent change could be used as a diagnostic tool.
Bill and Melinda Gates Foundation Grand Challenges Exploration

Contact: A'ndrea Elyse Messer
Penn State

Public Release: 30-Jun-2014
Women's groups recommended by WHO as an intervention to cut newborn deaths
The World Health Organisation has recommended an intervention developed and tested by partners in four countries and UCL researchers to improve maternal and newborn health.

Contact: Kate Hoyland
University College London

Public Release: 30-Jun-2014
Sixth class of Global Health Corps fellows begin year of service to advance health equity
Global Health Corps welcomed its sixth class of fellows today at Yale University, for the opening of its annual Leadership Training Institute. Selected from a pool of nearly 5,000 applicants, the incoming class of fellows -- the largest ever -- reflects the growing enthusiasm and commitment of millennials to engage globally and address inequities worldwide. Representing 22 countries, GHC's newest class will begin their year of service within health organizations across Africa and the United States.

Contact: Ann Clark

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Body odor reveals malarial infection
An infection with malaria pathogens changes the scent of infected mice, making those infected more attractive to mosquitos. These are the findings of a team of researchers from ETH Zurich and Pennsylvania State University in a new study.

Contact: Consuelo De Moraes
ETH Zurich

Public Release: 27-Jun-2014
USAMRIID research sheds light on how deadly lassa virus infects cells
An international team of scientists has discovered that the Lassa virus, endemic to West Africa, uses an unexpected two-step process to enter cells. The results, published in today's edition of Science, suggest that the mechanism by which Lassa virus causes infection is more complicated than previously known, and could lead to new approaches for preventing the disease. Collaborators included USAMRIID, the Netherlands Cancer Institute, the University of Kiel in Germany, and Harvard Medical School.
Defense Threat Reduction Agency, European Research Council, National Institutes of Health

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 27-Jun-2014
64th Lindau Nobel Laureate Meeting
Global healthcare is a labour of Hercules
Swedish Professor for Global Health and YouTube star Hans Rosling to give presentation at the opening of the 64th Lindau Nobel Laureate Meeting in Germany on June 29.

Contact: Christian Schumacher
Lindau Nobel Laureate Meetings

Public Release: 27-Jun-2014
Genome Biology
Scientists identify new pathogenic and protective microbes associated with severe diarrhea
Diarrhea is a major cause of childhood mortality in developing countries and ranks as one of the top four causes of death among young children in sub-Saharan Africa and South Asia. In a finding that may one day help control diarrhea, researchers have identified microorganisms that may trigger diarrheal disease and others that may protect against it. These microbes were not widely linked to the condition previously. The research results appear today in Genome Biology.
Bill & Melinda Gates Foundation, National Science Foundation, National Insitututes of Health, The Wellcome Trust

Contact: Tom Ventsias
University of Maryland

Public Release: 26-Jun-2014
PLOS Pathogens
Salmonella's Achilles' heel: Reliance on single food source to stay potent
Scientists have identified a potential Achilles' heel for Salmonella -- the bacteria's reliance on a single food source to remain fit in the inflamed intestine.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institute of General Medical Science

Contact: Brian Ahmer
Ohio State University

Public Release: 26-Jun-2014
European Respiratory Journal
Research says TB infection may be underestimated among people taking corticosteroid pills
Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests. Current guidelines for what constitutes a positive TB skin test among corticosteroid pill users may not be capturing all those who are infected, said Dr. Nicholas Vozoris, a respirologist in the Tuberculosis Program at St. Michael's Hospital.

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 25-Jun-2014
The Lancet
Deploying midwives in poorest nations could avert millions of maternal and newborn deaths
A modest increase in the number of skilled midwives in the world's poorest nations could save the lives of a substantial number of women and their babies, according to new analyses by researchers from the Johns Hopkins Bloomberg School of Public Health.
US Agency for International Development

Contact: Stephanie Desmon
Johns Hopkins University Bloomberg School of Public Health

Public Release: 25-Jun-2014
Lancet Infectious Diseases
First estimates of newborns needing treatment for bacterial infection show 7 million cases
Seven million babies in South Asia, sub-Saharan Africa and Latin America in 2012 required treatment for bacterial infections including sepsis, meningitis and pneumonia, according to research overseen by the London School of Hygiene & Tropical Medicine.

Contact: Joel Winston
London School of Hygiene & Tropical Medicine

Public Release: 25-Jun-2014
Science Translational Medicine
Researchers 1 step closer to countering deadly Nipah virus
An interdisciplinary research team from the University of Texas Medical Branch at Galveston, the Uniformed Services University of the Health Sciences and three groups within the National Institutes of Health reports a new breakthrough in countering the deadly Nipah virus. The human monoclonal antibody known as m102.4 is the first effective antiviral treatment for Nipah that has the potential for human therapeutic applications.
National Institutes of Health, US Department of Health and Human Services

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 23-Jun-2014
Proceedings of the National Academy of Sciences
Vaccine made from complex of two malaria proteins protects mice from lethal infection
An experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1, was developed more than decade ago by scientists from NIAID, part of NIH. It showed promise in test-tube and animal experiments and in early-stage clinical trials, but returned disappointing results in recent human trials conducted in malaria-endemic countries.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 23-Jun-2014
Nature Genetics
New study offers potential avenues for treatment of deadly nasopharyngeal cancer
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore, National University Cancer Institute Singapore and National University Hospital Singapore, discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing novel therapies for this deadly disease.

Contact: Kimberley Wang
National University of Singapore

Showing releases 976-1000 out of 1158.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>